Orexigen Therapeutics (OREX) Reports Q1 Loss of $4.67/Share
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Collaborative agreement: 895K
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Collaborative agreement: 895K
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Orexigen Therapeutics (NASDAQ: OREX) reported Q1 EPS of ($4.67), versus ($1.54) reported last year. Revenue for the quarter came in at $19.1 million versus the consensus estimate of $20 million.
For earnings history and earnings-related data on Orexigen Therapeutics (OREX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
- Similarweb Ltd. (SMWB) Tops Q2 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
